Mental Health and Suicidality in Glioblastoma Patients in Germany
Recruiting · NCT07409584 · Observational (researchers observe without assigning treatment) · Lead sponsor: University Hospital, Essen
View the official record on ClinicalTrials.gov →Interventions studied
Medical history, physical examination, completing questionnaires, data collection
What this trial is about
The aim of the study is to use standardized questionnaires to systematically record influencing factors or predictors for suicidal behavior in glioblastoma patients, particularly with regard to existing depression and anxiety symptoms.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Newly diagnosed glioblastoma, IDH wild-type (CNS WHO classification of 2021) after finishing radiotherapy (before first recurrence)
- Age ≥ 18 years
Exclusion criteria
- Participants with clinically significant aphasia or language barrier as assessed by the investigator
- History of other malignant tumors
- Known tumor predisposition syndrome (e.g., Li-Fraumeni syndrome, Cowden syndrome, etc.)
- Recurrent glioblastoma
Where it is running
6 locations listed.
- Charite - Berlin, Germany
- University Hospital Knappschaftskrankenhaus Bochum - Bochum, Germany
- University Hospital Essen - Essen, Germany
- University hospital Hamburg Eppendorf - Hamburg, Germany
- University hospital Heidelberg - Heidelberg, Germany
- University hospital Muenster - Münster, Germany